Research

AIDA

by gil5on | June 9, 2020 | Child Health & Development | 0 Comments

AIDA An integrated database for early child development in MalawiStart and End dates: 2019 to 2021 Source of Funding: UK Economic and Social Research Council ($63,000)This is a project where we are using a holistic, unified, approach to data acquisition of key factors...

BICO

by gil5on | June 9, 2020 | Child Health & Development | 0 Comments

BICO Impact of socio-biological risk factors on infant development in low-income countries - foundations for a large-scale longitudinal population study in Malawi Start and End dates: 2019 to 2021 Source of Funding: United Kingdom Research Institute (UKRI) ($187,000)...

EDCTP CDF

by gil5on | June 9, 2020 | Child Health & Development | 0 Comments

EDCTP CDF Efficacy, safety and pharmacokinetics of artemether lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in HIV infected Malawian children on antiretroviral treatment Start and End dates: 2020 to 2023 Source of Funding: European and...

CHEMCHA

by gil5on | June 9, 2020 | Child Health & Development | 0 Comments

CHEMCHA Dihydroartemisinin-Piperaquine for the Chemoprevention of Malaria in Children with Sickle Cell Anaemia in eastern and southern AfricaStart and End dates: 2019 to 2023 Source of Funding: Norwegian Research Council ($1.8million)This is an individual...

IMPROVE

by gil5on | June 9, 2020 | Maternal Health & Wellbeing | 0 Comments

IMPROVE Start and End dates: 2016 to 2020 Source of Funding: DFID/MRC/Wellcome Trust and European and Developing Countries Clinical Trials Partnership (EDCTP) ($1.8m) The overall aim of the study is to provide the WHO with definitive evidence to determine whether...

IMPROVE2

by gil5on | June 9, 2020 | Maternal Health & Wellbeing | 0 Comments

IMPROVE 2 IPTp with dihydroartemisinin-piperaquine and single-course azithromycin for malaria, sexually transmitted and reproductive tract infections in HIV-infected pregnant women in Kenya and Malawi: a multi-centre, 3-arm placebo-controlled trialStart and End dates:...

REVAMP

by gil5on | June 9, 2020 | Maternal Health & Wellbeing | 0 Comments

REVAMP Randomized controlled trial of the effect of intravenous iron on anemia in Malawian pregnant women Start and End dates: 2017 to 2022 Source of Funding: Bill & Melinda Gates Foundation ($1.6 million) An individual-randomized Phase III, open-label clinical...

REVAMP Accept

by gil5on | June 9, 2020 | Maternal Health & Wellbeing | 0 Comments

REVAMP Accept Randomized controlled trial of the effect of intravenous iron on anaemia in Malawian pregnant women (REVAMP): Feasibility and AcceptabilityStart and End dates: 2017 to 2022 Source of Funding: Bill & Melinda Gates Foundation ($20,000)This is a...

REVAMP Observe

by gil5on | June 9, 2020 | Maternal Health & Wellbeing | 0 Comments

REVAMP Observe Randomized controlled trial of the effect of intravenous iron on anaemia in Malawian pregnant women (REVAMP): Observation CohortStart and End dates: 2018 to 2022 Source of Funding: Bill & Melinda Gates Foundation ($0.75 million)This is a cohort...

REVAMP TT

by gil5on | June 9, 2020 | Maternal Health & Wellbeing | 0 Comments

REVAMP TT Randomized controlled trial of the effect of intravenous iron on anaemia in Malawian pregnant women (REVAMP): Third TrimesterStart and End dates: 2020 to 2024 Source of Funding: Bill & Melinda Gates Foundation ($4.6 million)This is an open-label clinical...